October 28, 2016
3 min watch

VIDEO: MedImmune collaborations produce three discoveries in COPD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

PHILADELPHIA — Roland Kolbeck, vice president of research and development for Respiratory, Inflammation & Autoimmunity at MedImmune, spoke with Healio Rheumatology about the company’s collaborations with academic institutions.

Kolbeck mentioned how MedImmune’s partnerships with academic institutions led to the discoveries that the interleukin-33 cytokine is expressed in the lungs of patients with chronic obstructive pulmonary disease (COPD), that immunoglobulin E binds to immune complexes in patients with lupus and that the innate lymphoid cell produces different types of cytokines from other cells in patients with COPD.